Medical Doctor Program year 2023 Source: CMS Open Payments, 2026 publication

Skotti Church

Geriatric Medicine Corvallis, OR Medical Doctor

NPI 1205060555 CMS profile 397271

3521 Nw Samaritan Dr Ste 201, Corvallis, OR 97330

Open in the dashboard

General payments

$19

1 record reported · program year 2023

Research payments

$0

Paid to them · None reported · program year 2023

Ownership & investment interest

$0

None reported

Through program year 2023, Skotti Church of Corvallis, OR is reported in the CMS Open Payments database as having received $19 across 1 general payment and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 8th percentile of Geriatric Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

1 row
Year Kind Relative to this record's peak year Amount Records
2023 General $19 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Skotti Church
  • Geriatric Medicine median
  • Middle half of Geriatric Medicine
  • National median

In program year 2025, general payments to Skotti Church were reported at $0. Among 1,028 Geriatric Medicine profiles paid that year, the median was $123 and the middle half received between $35 and $408.

Show as a table
Year Skotti Church Geriatric Medicine median Middle half National median
2019 $0 $122 $40–$435 $163
2020 $0 $98 $25–$349 $114
2021 $0 $125 $34–$441 $132
2022 $0 $124 $36–$408 $149
2023 $19 $121 $41–$383 $160
2024 $0 $134 $41–$435 $164
2025 $0 $123 $35–$408 $169

Breakdown

Who paid General payments · program year 2023
  1. Exact Sciences Corporation $19 1 payment

Every payment, record by record

What the payments were for General payments · program year 2023
  1. Food and Beverage $19 1 payment
Products named General payments · program year 2023
  1. Cologuard Collection Kit $19 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 84 drugs

Part D claims

4,095

Median for Internal Medicine: 777

Drug cost

$304,920

Median for Internal Medicine: $73,373

Branded share of claims

17%

Median for Internal Medicine: 19.3%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 166 $149,863
Jardiance Empagliflozin Brand 20 $16,756
Trelegy Ellipta Fluticasone/Umeclidin/Vilanter Brand 14 $12,183
Myrbetriq Mirabegron Brand 17 $12,134
Incruse Ellipta Umeclidinium Bromide Brand 24 $12,105
Premarin Estrogens, Conjugated Brand 17 $10,689
Xarelto Rivaroxaban Brand 15 $8,127
Symbicort Budesonide/Formoterol Fumarate Brand 17 $7,762
Atorvastatin Calcium Generic 313 $5,323
Fluticasone-Salmeterol Fluticasone Propion/Salmeterol Brand 24 $5,311

The 10 drugs with the highest cost, of 84 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 104,182 Part D prescribers listed as Internal Medicine; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 24 billing codes

Paid by Medicare

$42,322

Medicare's payments for the services billed

Medicare patients

301

Average age 78

Services billed

707

194 women, 107 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 69%
Arthritis 44%
Diabetes 27%
Atrial fibrillation 25%
Depression 24%
Chronic kidney disease 21%
Cancer 21%
Ischemic heart disease 20%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

1 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Geriatric Medicine in Oregon

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2023

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record